U.S. STOCKS Exxon Mobil, Mondelez International, Macy's
Eikon search string for individual stock moves: STXBZ
The Day Ahead newsletter: https://refini.tv/3LI4BU7
The Morning News Call newsletter: https://refini.tv/3dKUyB8
Wall Street's main indexes were set for a higher open on Wednesday after an in-line inflation reading kept intact bets on the Federal Reserve cutting interest rates later this month. .N
** Amazon.com Inc AMZN.O:
BUZZ - India's Swiggy, Zomato fall as Amazon enters quick commerce racenL4N3NC0BN
** Dave & Buster's Entertainment Inc PLAY.O:
BUZZ - Slides after Q3 revenue shortfall and CEO departure nL4N3NC0M3
** GE Vernova Inc GEV.N:
BUZZ - Forecasts lower 2025 revenue in wind segment; shares down nL4N3NC0NZ
** Stitch Fix Inc SFIX.O:
BUZZ - Surges on upbeat 2025 revenue forecast nL4N3NC0OS
** ImmunityBio Inc IBRX.O:
BUZZ - Plunges after pricing $100 mln stock offering at 35% discount nL4N3NC0W2
** Fluence Energy Inc FLNC.O:
BUZZ - Rises after upsized $350 mln convertible debt offering nL4N3NC0P1
** Cellectar Biosciences Inc CLRB.O:
BUZZ - Plunges on potential cancer drug sale nL4N3NC0QR
** General Motors Co GM.N:
BUZZ - Rises after co abandons Cruise robotaxi development nL4N3NC0RA
** Relay Therapeutics Inc RLAY.O:
BUZZ - Rises on interim data for cancer drug nL4N3NC0RY
** Krispy Kreme Inc DNUT.O:
BUZZ - Falls on cybersecurity incident report nL4N3NC0QZ
** CG Oncology Inc CGON.O:
BUZZ - Falls after unveiling stock offering nL4N3NC0QY
** EastGroup Properties Inc EGP.N:
** Prologis Inc PLD.N:
BUZZ - Raymond James adjusts ratings on industrial REITs nL4N3NC0SI
** Candel Therapeutics Inc CADL.O:
BUZZ - Surges as prostate cancer therapy meets main goal of late-stage study nL4N3NC0UC
** Figs Inc FIGS.N:
BUZZ - Rises on buyout bid nL6N3NC0FM
** Annovis Bio Inc ANVS.N:
BUZZ - Falls on planned $50 mln share sale nL4N3NC0UN
** Patterson Companies Inc PDCO.O:
BUZZ - Surges after $4.1 bln deal to go private nL4N3NC0WZ
** MannKind Corp MNKD.O:
BUZZ - Rises after India approves insulin inhalation powder nL4N3NC0WE
** Macy's Inc M.N:
BUZZ - Slides after cutting annual profit forecast nL4N3NC0TY
** Rocket Pharmaceuticals Inc RCKT.O:
BUZZ - Falls after upsized $165 mln stock offering nL4N3NC0WK
** Q32 Bio Inc QTTB.O:
BUZZ - Tumbles after mid-stage trial setback for dermatitis drug nL4N3NC0Y9
** Exxon Mobil Corp XOM.N:
BUZZ - Forecasts higher capex in 2025; shares fall nL4N3NC0YU
** Reddit Inc RDDT.N:
BUZZ - Gains as Wells Fargo joins the bulls with Street-high PT nL6N3NC0GZ
** Mondelez International Inc MDLZ.O:
BUZZ - Rises on new $9 bln share buyback program, "bolt-on" acquisition strategy nL4N3NC10U
(Compiled by Rajarshi Roy and Anshuman Tripathy)
</body></html>Related Assets
Latest News
Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.
All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.
Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.
